Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study. (Q48480217)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Gabriele Stoffels

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

M D Piroth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

M Pinkawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

R Holy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

J Klotz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

S Schaar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

N Galldiks

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

H H Coenen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

H J Kaiser

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

M J Eble

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

22 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

Strahlentherapie und Onkologie

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

334-339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00066-011-0060-5

23 January 2020

exact match

0 references

cites work

Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

The linear-quadratic formula and progress in fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

18F-FET-PET-based dose painting by numbers with protons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0060-5

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22349712

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00066-011-0060-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22349712%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference